Common genomic features shared by benign, borderline, and malignant mucinous ovarian tumors include the overall mutational burden and the number of point mutations.TP53 pathogenic variants, which increase significantly in malignancy, suggest a driving role in the malignant evolution of these tumors (46, 48). The gene discussed is TP53; the disease is ovarian mucinous neoplasm.